Arendal en es it fr

Arendal Brand names, Arendal Analogs

Arendal Brand Names Mixture

  • No information avaliable

Arendal Chemical_Formula


Arendal RX_link

Arendal fda sheet

Arendal FDA

Arendal msds (material safety sheet)

Arendal MSDS

Arendal Synthesis Reference

M. I. Kabachnik et al., Bull. Acad. Sci. USSR,.27, 374 (1978)

Arendal Molecular Weight

249.096 g/mol

Arendal Melting Point

233 - 235 oC

Arendal H2O Solubility


Arendal State


Arendal LogP


Arendal Dosage Forms

Tablets (6.53, 13.05, 45.68, 52.21 or 91.37 mg of alendronate monosodium salt trihydrate)

Arendal Indication

For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.

Arendal Pharmacology

Alendronate, a second-generation bisphosphonate is the first member of a group of drugs which strengthens bone. Alendronate is used to reduce hypercalcemia in tumor-induced bone disease, to treat corticosteroid-induced osteoporosis and Paget's disease, and to prevent osteoporosis in postmenopausal women.

Arendal Absorption

Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast.

Arendal side effects and Toxicity

Alendronate can damage the esophagus both by toxicity from the medication itself and by nonspecific irritation secondary to contact between the pill and the esophageal mucosa, similar to other cases of "pill esophagitis."

Arendal Patient Information

Arendal Organisms Affected

Humans and other mammals